TEM NASDAQ
Tempus AI, Inc.
1W: +8.1%
1M: -15.2%
3M: +73.7%
YTD: +15.7%
1Y: -19.1%
$72.15
+4.99 (+7.43%)
Weekly Expected Move ±11.7%
$52
$60
$68
$76
$83
Credit Risk of going bust: higher than 64% of companies Debt: 10.1% of company value Bonds: $80.4M held by 38 funds → details ▾
Of US companies ranked in the middle of the pack, about 1 in 580 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.12 (down 98%), Tempus AI, Inc. would be worth roughly what it owes.
Total debt $1.44B against a stock market value of $12.78B.
Distance to default 3.95 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $680.4M (short-term plus half of long-term), stock volatility 74.0%; Altman Z'' -1.31. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
If the stock fell to about $1.12 (down 98%), Tempus AI, Inc. would be worth roughly what it owes.
Total debt $1.44B against a stock market value of $12.78B.
Distance to default 3.95 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $680.4M (short-term plus half of long-term), stock volatility 74.0%; Altman Z'' -1.31. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships3
As Filer
counterparties named
3
As Counterparty
mentioned by others
2
Rel. Types
2024-08-16
Earliest Filing
2025-07-09
Latest Filing
target: 2
acquirer: 1
Counterparties (Filed by TEM)
3 relationshipsCompanies named in TEM's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| REALM IDx, Inc. | — | target | Seller of Ambry Genetics Corporation stock in acquisition | 2024-11-05 | View |
| Konica Minolta, Inc. | — | acquirer | Ultimate parent of the Seller | 2024-11-05 | View |
| Ambry Genetics Corporation | — | target | Target company being acquired | 2024-11-05 | View |
Mentioned As Counterparty
3 mentionsOther companies that named TEM in their SEC 8-K filings.
| Filed By | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|
| PSNL Personalis, Inc. | partner | Amendment to Commercialization and Reference Laboratory Agreement for NeXT Personal® marketing in colorectal cancer | 2025-07-09 | View |
| PSNL Personalis, Inc. | partner | Amended Commercialization and Reference Laboratory Agreement to market and sell Personalis' NeXT Personal test. | 2024-12-19 | View |
| PSNL Personalis, Inc. | investor | Invested in Personalis, Inc. via an investment agreement and exercised warrants to purchase common stock. | 2024-08-16 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-23 | Other Events | View | |
| 2026-07-30 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-07-20 | Regulation FD; Exhibits | View | |
| 2026-07-20 | Material Agreement; Exhibits | Agreement | View |
| 2026-05-22 | Shareholder Vote | View | |
| 2026-05-13 | Material Agreement; Termination of Agreement; Financial Obligation; Unregistered Equity Sales; Other | Agreement | View |
| 2026-05-05 | Earnings Release; Regulation FD; Exhibits | View | |
| 2026-02-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2026-01-12 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-11-04 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-08-27 | Other Events; Financial Statements and Exhibits | View | |
| 2025-08-08 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-07-03 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Unregistered Sale | Agreement | View |
| 2025-05-23 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-06 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-04-23 | Other Events | View | |
| 2025-02-24 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2025-02-03 | Entry into Material Definitive Agreement; Creation of Direct Financial Obligation; Financial Stateme | Agreement | View |
| 2025-01-13 | Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Ex | View | |
| 2024-11-05 | Entry into Material Definitive Agreement; Unregistered Sales of Equity Securities; Financial Stateme | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR